BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23056546)

  • 1. Association between CYP1A1 Ile462Val variation and acute leukemia risk: meta-analyses including 2164 cases and 4160 controls.
    Zhuo W; Zhang L; Zhu B; Qiu Z; Chen Z
    PLoS One; 2012; 7(10):e46974. PubMed ID: 23056546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 1A1 Ile462Val polymorphism and oral carcinoma risk: an updated meta-analysis including 1,515 cases and 2,233 controls.
    Zhuo X; Zhao H; Chang A; Ye H; Zhou Y; Song Y; Tan Y
    Tumour Biol; 2012 Dec; 33(6):2079-89. PubMed ID: 22847262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association between the CYP1A1 Ile462Val polymorphism and endometrial cancer risk: a meta-analysis.
    Wang XW; Zhong TY; Xiong YH; Lin HB; Liu QY
    Asian Pac J Cancer Prev; 2012; 13(8):3717-21. PubMed ID: 23098461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP1A1 Ile462Val polymorphism contributes to colorectal cancer risk: a meta-analysis.
    Jin JQ; Hu YY; Niu YM; Yang GL; Wu YY; Leng WD; Xia LY
    World J Gastroenterol; 2011 Jan; 17(2):260-6. PubMed ID: 21246002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP1A1 Ile462Val is a risk factor for ovarian cancer development.
    Huang M; Chen Q; Xiao J; Zhao X; Liu C
    Cytokine; 2012 Apr; 58(1):73-8. PubMed ID: 22277800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cytochrome P4501A1 gene polymorphisms and endometriosis: a meta-analysis.
    Fan W; Huang Z; Xiao Z; Li S; Ma Q
    J Assist Reprod Genet; 2016 Oct; 33(10):1373-1383. PubMed ID: 27525656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP1A1 Ile462Val polymorphism and cervical cancer: evidence from a meta-analysis.
    Yang S; Jia C; Zhu H; Han S
    Tumour Biol; 2012 Dec; 33(6):2265-72. PubMed ID: 22948778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative synthesis of the association between the cytochrome P450 1A1 Ile462Val polymorphism and prostate cancer risk.
    Han G; Ma Y; Liu P; Wei X; Zhang X; Zhu F
    Tumour Biol; 2013 Jun; 34(3):1511-6. PubMed ID: 23381648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does cytochrome P450 1A1 MspI polymorphism increase acute lymphoblastic leukemia risk? Evidence from 2013 cases and 2903 controls.
    Zhuo W; Zhang L; Qiu Z; Zhu B; Chen Z
    Gene; 2012 Nov; 510(1):14-21. PubMed ID: 22964275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 1A1 (CYP1A1) polymorphism and susceptibility to esophageal cancer: an updated meta-analysis of 27 studies.
    Gong FF; Lu SS; Hu CY; Qian ZZ; Feng F; Wu YL; Yang HY; Sun YH
    Tumour Biol; 2014 Oct; 35(10):10351-61. PubMed ID: 25048966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of association studies of CYP1A1 genetic polymorphisms with digestive tract cancer susceptibility in Chinese.
    Liu C; Jiang Z; Deng QX; Zhao YN
    Asian Pac J Cancer Prev; 2014; 15(11):4689-95. PubMed ID: 24969905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association of CYP1A1 Ile462Val polymorphisms with susceptibility to small cell lung cancer].
    He B; Lin J; Cao L; Wang H; Rao J; Liu Y; Zhang Z
    Wei Sheng Yan Jiu; 2014 May; 43(3):393-6, 418. PubMed ID: 24964616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between CYP1A1 polymorphisms and cigarette smoking are associated with the risk of hepatocellular carcinoma: evidence from epidemiological studies.
    Yu L; Sun L; Jiang YF; Lu BL; Sun DR; Zhu LY
    Mol Biol Rep; 2012 Jun; 39(6):6641-6. PubMed ID: 22297691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis.
    Zheng Y; Wang JJ; Sun L; Li HL
    Mol Biol Rep; 2012 Apr; 39(4):3533-40. PubMed ID: 21710246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP1A1 Ile462Val polymorphism contributes to lung cancer susceptibility among lung squamous carcinoma and smokers: a meta-analysis.
    Ji YN; Wang Q; Suo LJ
    PLoS One; 2012; 7(8):e43397. PubMed ID: 22952673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XRCC1 Arg399Gln variation and leukemia susceptibility: evidence from 2,647 cases and 5,518 controls.
    Huang Y; Xie D; Tang N; Wang J; Zeng X; Zhao P; He L
    Tumour Biol; 2014 Jan; 35(1):799-808. PubMed ID: 23990457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 1A1 gene polymorphisms and cervical cancer risk: A systematic review and meta-analysis.
    Ding B; Sun W; Han S; Cai Y; Ren M; Shen Y
    Medicine (Baltimore); 2018 Mar; 97(13):e0210. PubMed ID: 29595663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP1A1 MspI polymorphism and acute myeloid leukemia risk: meta-analyses based on 5018 subjects.
    Zhuo W; Zhang L; Wang Y; Zhu B; Chen Z
    J Exp Clin Cancer Res; 2012 Jul; 31(1):62. PubMed ID: 22846179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk.
    Basham VM; Pharoah PD; Healey CS; Luben RN; Day NE; Easton DF; Ponder BA; Dunning AM
    Carcinogenesis; 2001 Nov; 22(11):1797-800. PubMed ID: 11698341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP1A1 Ile462Val polymorphism as a risk factor in cervical cancer development in the Polish population.
    Roszak A; Lianeri M; Sowińska A; Jagodziński PP
    Mol Diagn Ther; 2014 Aug; 18(4):445-50. PubMed ID: 24626963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.